13F HOLDINGS REPORT
Affinity Asset Advisors, LLC
Quarter ended Q2 2025 · Filed August 13, 2025 · Accession 0001999371-25-011256
Total Value
$732.2M
Positions
91
Other Managers
0
Confidential Omitted
No
Holdings (91)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VERONA PHARMA PLC | 925050106 | 610,000 | $57.7M | 7.88% |
| 2 | INSMED INC | INSM | 475,000 | $47.8M | 6.53% |
| 3 | XENON PHARMACEUTICALS INC | XENE | 1,100,000 | $34.4M | 4.70% |
| 4 | ARCELLX INC | ACLX | 495,000 | $32.6M | 4.45% |
| 5 | BLUEPRINT MEDICINES CORP | 09627Y109 | 250,000 | $32.0M | 4.38% |
| 6 | NUVALENT INC | NUVL | 415,000 | $31.7M | 4.32% |
| 7 | APOGEE THERAPEUTICS INC | APGE | 691,899 | $30.0M | 4.10% |
| 8 | ALKERMES PLC | ALKS | 1,000,000 | $28.6M | 3.91% |
| 9 | PROTAGONIST THERAPEUTICS INC | PTGX | 440,000 | $24.3M | 3.32% |
| 10 | MADRIGAL PHARMACEUTICALS INC | MDGL | 80,000 | $24.2M | 3.31% |
| 11 | TEVA PHARMACEUTICAL INDS LTD | 881624209 | 1,400,000 | $23.5M | 3.20% |
| 12 | EXELIXIS INC | EXEL | 450,000 | $19.8M | 2.71% |
| 13 | LEXEO THERAPEUTICS INC | LXEO | 3,589,355 | $14.4M | 1.97% |
| 14 | TRAVERE THERAPEUTICS INC | TVTX | 970,000 | $14.4M | 1.96% |
| 15 | ESTABLISHMENT LABS HLDGS INC | ESTA | 334,863 | $14.3M | 1.95% |
| 16 | TREVI THERAPEUTICS INC | TRVI | 2,534,058 | $13.9M | 1.89% |
| 17 | WAVE LIFE SCIENCES LTD | WVE | 2,000,308 | $13.0M | 1.78% |
| 18 | VERA THERAPEUTICS INC | VERA | 545,000 | $12.8M | 1.75% |
| 19 | MINERALYS THERAPEUTICS INC | MLYS | 900,000 | $12.2M | 1.66% |
| 20 | CENTESSA PHARMACEUTICALS PLC | CNTA | 900,162 | $11.8M | 1.62% |
| 21 | KARYOPHARM THERAPEUTICS INC | KPTI | 15,250,000 | $11.6M | 1.59% |
| 22 | AMGEN INC | AMGN | 40,000 | $11.2M | 1.53% |
| 23 | NURIX THERAPEUTICS INC | NRIX | 967,620 | $11.0M | 1.51% |
| 24 | REZOLUTE INC | RZLT | 2,200,000 | $9.8M | 1.34% |
| 25 | CRISPR Therapeutics AG | CRSP | 200,000 | $9.7M | 1.33% |
| 26 | VENTYX BIOSCIENCES INC | 92332V107 | 4,536,182 | $9.7M | 1.33% |
| 27 | SPYRE THERAPEUTICS INC | SYRE | 606,678 | $9.1M | 1.24% |
| 28 | ENLIVEN THERAPEUTICS INC | ELVN | 400,000 | $8.0M | 1.10% |
| 29 | PROQR THRAPEUTICS N V | N71542109 | 3,499,512 | $7.1M | 0.98% |
| 30 | AKEBIA THERAPEUTICS INC | AKBA | 1,950,000 | $7.1M | 0.97% |
| 31 | OMEROS CORP | OMER | 9,025,000 | $7.1M | 0.97% |
| 32 | INOZYME PHARMA INC | 45790W108 | 1,749,359 | $7.0M | 0.96% |
| 33 | AUTOLUS THERAPEUTICS PLC | AUTL | 3,045,000 | $6.9M | 0.95% |
| 34 | ORUKA THERAPEUTICS INC | ORKA | 603,479 | $6.8M | 0.92% |
| 35 | TRAVERE THERAPEUTICS INC | TVTX | 7,000,000 | $6.7M | 0.91% |
| 36 | EXELIXIS INC | EXEL | 150,000 | $6.6M | 0.90% |
| 37 | BRIDGEBIO PHARMA INC | BBIO | 150,000 | $6.5M | 0.88% |
| 38 | VIRIDIAN THERAPEUTICS INC | VRDN | 390,000 | $5.5M | 0.74% |
| 39 | AXSOME THERAPEUTICS INC | AXSM | 50,000 | $5.2M | 0.71% |
| 40 | ERASCA INC | ERAS | 4,085,787 | $5.2M | 0.71% |
| 41 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 275,000 | $5.0M | 0.68% |
| 42 | CRESCENT BIOPHARMA INC. | CBIO | 280,031 | $4.5M | 0.62% |
| 43 | ROIVANT SCIENCES LTD | ROIV | 400,000 | $4.5M | 0.62% |
| 44 | CRINETICS PHARMACEUTICALS IN | CRNX | 152,252 | $4.4M | 0.60% |
| 45 | VAXCYTE INC | PCVX | 125,000 | $4.1M | 0.56% |
| 46 | PERCEPTIVE CAP SOLUTIONS COR | G70077105 | 350,000 | $3.7M | 0.51% |
| 47 | MERUS N V | N5749R100 | 70,000 | $3.7M | 0.50% |
| 48 | PERSPECTIVE THERAPEUTICS INC | CATX | 1,050,000 | $3.6M | 0.49% |
| 49 | AVALO THERAPEUTICS INC | AVTX | 607,872 | $3.0M | 0.41% |
| 50 | OAKTREE ACQUISITION CORP III | OACCW | 250,000 | $2.7M | 0.36% |
| 51 | JAZZ PHARMACEUTICALS PLC | JAZZ | 25,000 | $2.7M | 0.36% |
| 52 | MONOPAR THERAPEUTICS INC | MNPR | 67,500 | $2.4M | 0.33% |
| 53 | RAPPORT THERAPEUTICS INC | RAPP | 199,643 | $2.3M | 0.31% |
| 54 | GERON CORP | GERN | 1,500,000 | $2.1M | 0.29% |
| 55 | THIRD HARMONIC BIO INC | 88427A107 | 370,000 | $2.0M | 0.27% |
| 56 | CULLINAN THERAPEUTICS INC | CGEM | 263,817 | $2.0M | 0.27% |
| 57 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 245,000 | $2.0M | 0.27% |
| 58 | UNIQURE NV | QURE | 135,000 | $1.9M | 0.26% |
| 59 | CLIMB BIO INC | CLYM | 1,500,000 | $1.9M | 0.25% |
| 60 | CAPRICOR THERAPEUTICS INC | CAPR | 175,000 | $1.7M | 0.24% |
| 61 | ANTERIS TECHNOLOGIES GLOBAL | AVR | 425,000 | $1.6M | 0.22% |
| 62 | ASTRIA THERAPEUTICS INC | 04635X102 | 300,000 | $1.6M | 0.22% |
| 63 | NOVAVAX INC | NVAX | 250,000 | $1.6M | 0.22% |
| 64 | UNIQURE NV | QURE | 100,000 | $1.4M | 0.19% |
| 65 | NKARTA INC | NKTX | 800,000 | $1.3M | 0.18% |
| 66 | MIRUM PHARMACEUTICALS INC | MIRM | 24,692 | $1.3M | 0.17% |
| 67 | SAVARA INC | SVRA | 500,000 | $1.1M | 0.16% |
| 68 | OLEMA PHARMACEUTICALS INC | OLMA | 250,000 | $1.1M | 0.15% |
| 69 | NEXTCURE INC | NXTC | 2,302,598 | $1.1M | 0.14% |
| 70 | OMEROS CORP | OMER | 314,000 | $942,000 | 0.13% |
| 71 | ONKURE THERAPEUTICS INC | OKUR | 347,990 | $831,696 | 0.11% |
| 72 | INMUNE BIO INC | INMB | 354,000 | $817,740 | 0.11% |
| 73 | ALTIMMUNE INC | ALT | 200,000 | $774,000 | 0.11% |
| 74 | ABIVAX SA | AAVXF | 100,000 | $765,000 | 0.10% |
| 75 | KARYOPHARM THERAPEUTICS INC | KPTI | 157,500 | $678,825 | 0.09% |
| 76 | JADE BIOSCIENCES INC | JBIO | 65,317 | $652,517 | 0.09% |
| 77 | SUTRO BIOPHARMA INC | STRO | 752,722 | $537,368 | 0.07% |
| 78 | GALECTIN THERAPEUTICS INC | GALT | 250,000 | $527,500 | 0.07% |
| 79 | TAYSHA GENE THERAPIES INC | TSHA | 200,000 | $462,000 | 0.06% |
| 80 | CONTEXT THERAPEUTICS INC | CNTX | 518,025 | $339,410 | 0.05% |
| 81 | ENGENE HOLDINGS INC | ENGNW | 77,000 | $280,280 | 0.04% |
| 82 | REPARE THERAPEUTICS INC | 760273102 | 200,000 | $278,000 | 0.04% |
| 83 | ZURA BIO LTD | ZURA | 223,335 | $234,502 | 0.03% |
| 84 | OVID THERAPEUTICS INC | OVID | 667,516 | $220,214 | 0.03% |
| 85 | RADIOPHARM THERANOSTICS LTD | RDPTF | 35,635 | $166,059 | 0.02% |
| 86 | APOGEE THERAPEUTICS INC | APGE | 2,500 | $108,575 | 0.01% |
| 87 | ADAGIO MED HLDGS INC | 00534B100 | 80,000 | $108,000 | 0.01% |
| 88 | Q32 BIO INC | QTTB | 27,777 | $41,388 | 0.01% |
| 89 | ARBUTUS BIOPHARMA CORP | ABUS | 9,300 | $28,737 | 0.00% |
| 90 | ROCKET PHARMACEUTICALS INC | RCKTW | 75,000 | $2,160 | 0.00% |
| 91 | IMMATICS N.V | IMTX | 187,204 | $112 | 0.00% |